Wednesday 30 November 2022
Psychedelic Stock News - Red Light Holland (CSE: TRIP) Reports Second Quarter 2023 Financial Results
Psychedelic Stock News - Red Light Holland (CSE: TRIP) Reports Second Quarter 2023 Financial Results
Investor Ideas #Potcasts 639, #Cannabis News and #Stocks on the Move- (CSE: $IWIN.C), (OTCQB: $XBRAF), (NASDAQ: $VLNS), (CSE: $RIV.C), (Nasdaq: $HITI)
Investor Ideas #Potcasts 639, #Cannabis News and #Stocks on the Move- (CSE: $IWIN.C), (OTCQB: $XBRAF), (NASDAQ: $VLNS), (CSE: $RIV.C), (Nasdaq: $HITI)
Vancouver, Delta, Kelowna, BC, November 30, 2022
(Investorideas.com Newswire), investorideas.com, a global news source covering leading sectors
including marijuana and hemp stocks and its potcast site
release today’s podcast edition of cannabis news and stocks to watch plus insight
from thought leaders and experts.
Listen to the podcast:
https://www.investorideas.com/Audio/Podcasts/2022/113022-StocksToWatch.mp3
Read this in full at https://www.investorideas.com/news/2022/cannabis-potcasts/11301IWIN-XBRAF-VLNS-RIV-HITI.asp
Hear Investor ideas
cannabis potcast on iTunes
Hear the investor
ideas potcast on Spotify
Today’s podcast overview/transcript:
In today’s podcast we look at a few
public company announcements covering areas such as membership programs,
beverages, Canadian LP’s and Psychedelics.
High Tide Inc. (Nasdaq: HITI) (TSXV: HITI) announced the launch of Cabana Elite, an
optional paid membership upgrade for Cabana Club members. Starting today,
customers can sign up for ELITE in-store and online at www.cannacabana.com. The Company expects that
ELITE will extend the Cabana Club membership program, attract new customers and
instil even greater customer loyalty. The Company anticipates that further
discounts, benefits and promotions will be regularly added to ELITE.
"I
am delighted to finally announce the launch of ELITE, the next evolution in our
innovative discount club model and a huge milestone for High Tide. The
continuous innovation from our team has positioned us as a top-performing
Canadian cannabis company, and ELITE is the natural result of this success. By
leveraging the strengths of our diversified cannabis ecosystem, we are
providing additional value to ELITE members by offering discounts on High
Tide's global online consumption accessories platforms. We see this as a big
step towards building our loyalty program into a global cannabis community as
we continue to convert price-conscious consumers from the illicit market into
our legal cannabis ecosystem," said Raj Grover, President and Chief
Executive Officer of High Tide.
"Our
goal is to sign up as many Cabana Club members to ELITE as possible within the
first year, following which we anticipate an even greater financial impact in
subsequent years. During these inflationary times, we decided to offer the
ELITE membership at a 50% discount for a limited time to allow our customers to
try out the new program at a minimum cost. Once our customers see what ELITE
has to offer, we anticipate they will look to maintain their status in
subsequent years. Launching ELITE was not an easy task, given the varied
regulatory landscape in the Canadian provinces where we operate. Our team has
been working hard on this project for many months, and I want to take this
opportunity to extend my sincere gratitude to our team members and provincial
regulators, who helped us get to this pivotal day. We are confident ELITE will
generate excellent returns for our shareholders, who can rely on High Tide for
continued innovation and execution," added Mr. Grover.
RIV Capital Inc. (CSE: RIV) (OTC: CNPOF), an acquisition and investment
firm with a focus on building a leading multistate platform with one of the
strongest portfolios of brands in key strategic U.S. markets, today released its financial results for the
three and six months ended September 30, 2022 ("FQ2 2023").
FQ2
2023 Highlights
●
Received New York State Cannabis Control
Board ("CCB") and New York State Office of Cannabis Management
("OCM") approval for Etain, LLC's change of control request, clearing
the path for the Company to complete the final closing of the previously
announced acquisition of ownership and control of Etain IP LLC and Etain, LLC
(collectively, "Etain") (the "Etain Acquisition")
●
Entered into a lease agreement with Zephyr,
a leading California-based developer, for the development and operation of a
planned new flagship cannabis cultivation and manufacturing facility in
Buffalo, New York
●
$165 million of cash on-hand to, among
other things, support the completion of the Etain Acquisition, the expansion
and development of Etain's cultivation and processing facilities, and to pursue
new growth opportunities
●
Reported a net loss of $142.3 million,
including a goodwill impairment charge of $138.9 million related to the Etain
Acquisition
"Having
cleared all regulatory hurdles, we are eager to complete the final closing of
the Etain Acquisition before the end of 2022, establishing RIV Capital as a
strongly positioned, vertically integrated cannabis operator in New York,"
said Mark Sims, President and CEO of RIV Capital. "With the long-awaited
drafts of New York cannabis market regulations approved for publication last
week, we are looking forward to continuing to work with the State to help create
an efficient market where registered organisations can operate effectively. We
intend to provide our feedback during the public review period and continue to
work with the regulators to support the creation of rules that are mutually
beneficial for all stakeholders."
"The
draft regulations further support our thesis that there will be a robust
wholesale market in New York, where the most successful companies will be those
that can build the strongest brands. New York continues to offer us the best
platform to launch our brand-focused strategy, and our expanding cultivation
footprint designed to support the premium New York market provides RIV Capital
with attractive wholesale opportunities."
Eddie
Lucarelli, Chief Financial Officer of RIV Capital, added, "In this
environment where access to capital and liquidity continues to be challenging
for many cannabis companies, we believe we remain well positioned with a strong
balance sheet to execute our expansion strategy in New York and simultaneously
evaluate other growth and capital allocation opportunities."
The Valens Company
Inc.
(TSX: VLNS) (NASDAQ: VLNS) announced that its shareholders have voted in
favour of the resolution approving the plan of arrangement pursuant to which SNDL Inc. will acquire all of the
issued and outstanding common shares of Valens on the basis of 0.3334 of a SNDL
common share for each outstanding Valens common share, on and subject to the
terms of the arrangement agreement dated August 22, 2022 to which Valens and
SNDL are parties. Over 96% of votes cast at the Company's special meeting of
shareholders held on November 29, 2022 were in favour of the Resolution.
"With
this announcement, we are one step closer to combining two best-in-class
cannabis companies that have extremely complementary assets to create a true
market leader. This pro forma company will create Canada's first large
vertically integrated cannabis company that unites SNDL's exceptional balance
sheet and largest cannabis retail network in Canada with Valens' low-cost
manufacturing platform. We look forward to taking Valens' brands to new heights
and unlocking 2.0 products for the SNDL platform," said Tyler Robson,
Chief Executive Officer of The Valens Company. "We believe the pro forma
company provides investors with attractive exposure not only to the highest
revenue generating cannabis company in Canada trading well under its tangible
book value but also a dominant platform that can become a global leader in
cannabis."
Xebra Brands Ltd. (CSE: XBRA) (OTCQB: XBRAF) announced that its cannabis infused beverage
Vicious Citrus OG, is a top performer, based on multiple metrics, in Ontario,
Canada's largest Cannabis market where more than 1,300 cannabis retailers are
based.
OG
is the first launch of several non-carbonated lemonade products under the
Vicious Citrus brand. OG, which stands
for "Original", is differentiated by its non-carbonated profile and
the addition of CBN, a unique cannabinoid that works synergistically with THC,
to enhance the overall effect.
Vicious
Citrus OG launched in Ontario in August 2022, and in only approximately 10
weeks, is the best-selling non-carbonated lemonade, the best-selling lemonade,
the fastest growing lemonade in sales, in the top 20% of all cannabis beverage
SKU's sold in Ontario, and in the top 1/3 of all cannabis beverage brands based
on sales.
Vicious
Citrus OG is also retailing in Saskatchewan, and is expected to be available
soon in British Columbia, Alberta and Manitoba.
"Vicious
Citrus OG is off to a strong start in Canada," said Jay Garnett, CEO of
Xebra Brands, "Budtender and consumer feedback has been exceptionally
positive, and we are confident the brand will continue to grow in current
markets as well as expand into new ones."
Xebra
management is considering introducing the Vicious Citrus brand outside Canada
and is taking steps to assess opportunities.
Irwin Naturals Inc. (CSE: IWIN) (OTC: IWINF) announced today that it reached a binding,
arms-length, agreement to acquire Serenity Health, LLC in Louisville, Kentucky,
on November 25, 2022. The move continues Irwin’s national ketamine clinic
rollup strategy that has seen the Company move quickly toward its goal of
building Irwin Naturals Emergence into the world’s largest chain of psychedelic
mental health clinics. Irwin Naturals was founded in 1994, building itself into
a nationally renowned company with its first-in-class line of nutraceuticals
that are available in more than 100,000 stores across North America. The Irwin
Naturals brand is recognized in 80 percent of American households.
Klee
Irwin, CEO of Irwin Naturals, said, “With each clinic we bring under the
umbrella of Irwin Naturals Emergence, we take another step toward the forefront
of this new approach to mental healthcare. We are the world’s first household
name to enter the space and are moving fast with the goal of being the first
mover in this market.”
Irwin
Naturals Emergence already includes clinics in Florida, Vermont, New Hampshire,
Iowa, and Georgia. Currently, ketamine is the only psychedelic available for
use in the United States outside of clinical trials when used as prescribed.
However, MDMA and psilocybin may be authorised for therapeutic use in the
future. This creates the possibility of radically changing the way we treat
mental-health concerns.
Beth
Ann Nevius, co-founder and CEO of Serenity Health, said, “What impressed us
about Irwin’s approach to America’s mental health crisis is its philosophy of
using national scale to drive down patient costs. Furthermore, the Irwin team
has proven itself capable of building a national brand with an exceptionally
faithful customer base. We are looking forward to becoming part of the Irwin
team and taking this great brand nationwide, making mental healthcare
accessible to all.”
Irwin
Naturals Emergence is a wholly owned subsidiary of Irwin Naturals, and it was
formed when the Company decided to enter the fast-growing sector of psychedelic
mental healthcare. Over the past year, Irwin Naturals Emergence has identified
ketamine clinics that practise a high standard of care to explore the possibility
of adding these clinics to the national chain. This offers the possibility of
increased economic efficiency because of the national scale of the operation
that could help drive down operating costs, making it possible to pass savings
along to the consumer in the form of sliding-scale discounts and even pro-bono
treatments for those in need. Irwin Naturals’ name and reputation makes it an
impactful voice in this new area of mental healthcare due to the Company’s
history in safely caring for the health of its patients vouching for the safety
and the efficacy of psychedelic treatment.
Irwin
added, “We see ourselves as the Coca Cola first mover, and will be leveraging
our brand equity and status as a cult brand to expand rapidly as society
embraces the psychedelic mental health revolution. This is important because,
as a psychedelic, ketamine is an effective treatment for many mental health
disorders. However, some Americans are not clear on its potential. The trusted
Irwin brand will be the welcome face of a familiar friend in a crowd of
strangers – making this life-saving solution a bit less intimidating to those
in need.”
The
Agreement is subject to certain customary closing conditions and regulatory
approvals. The total consideration will be paid in upfront and deferred
consideration. Also included are contingent payments based on milestones
related to expansion and profitability goals.
Investor ideas reminds all listeners to read our disclaimers and
disclosures on the Investorideas.com website and that this podcast is not an
endorsement to buy products or services or securities. Investors are reminded
all investment involves risk and possible loss of investment.
To hear more Investorideas.com
podcasts visit: https://www.investorideas.com/Audio/.
The Investorideas.com podcasts are also
available on iTunes ( Apple Podcasts) ,
Audible , Spotify, Tunein, Stitcher, Spreaker.com, iHeartRadio , Google Podcasts and most audio platforms
available.
About
Investorideas.com - Big Investing Ideas
We publish breaking
stock news, stock research, guest posts and create original top rated investing
podcasts, plus sector tag articles featuring up and coming companies and
industry leaders. Investor Idea’s
original branded content includes the Crypto
Corner Podcast , Play by Play Sports Podcast , Cannabis News and Stocks on the Move Podcast , Cleantech and Climate Change Podcast, Exploring Mining Podcast , Betting on Gaming Stocks Podcast and the AI Eye Podcast. We also create free investor stock directories
for AI and tech, biotech, cannabis, cleantech, crypto, defense, gaming, health
and wellness, mining, oil and gas, sports and water.
Disclaimer/Disclosure: Investorideas.com is
a digital publisher of third party sourced news, articles and equity research
as well as creates original content, including video, interviews and articles.
Original content created by investorideas is protected by copyright laws other
than syndication rights. Our site does not make recommendations for purchases
or sale of stocks, services or products. Nothing on our sites should be
construed as an offer or solicitation to buy or sell products or securities.
All investing involves risk and possible losses. This site is currently
compensated for news publication and distribution, social media and marketing,
content creation and more. Disclosure is posted for each compensated news
release, content published /created if required but otherwise the news was not
compensated for and was published for the sole interest of our readers and
followers. Contact management and IR of each company directly regarding
specific questions. Disclosure: GTCH is
a paid featured Ai stock .More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn
more about publishing your news release and our other news services on the
Investorideas.com newswire https://www.investorideas.com/News-Upload/
Global investors must adhere to regulations of each country. Please read
Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Follow us on
Twitter https://twitter.com/Investorideas
Follow us on
Facebook https://www.facebook.com/Investorideas
Follow us on
YouTube https://www.youtube.com/c/Investorideas
Contact Investorideas.com
800 665 0411
Monday 28 November 2022
Wednesday 23 November 2022
Thursday 17 November 2022
Wednesday 16 November 2022
Tuesday 15 November 2022
Thursday 10 November 2022
Investor Ideas #Potcasts, #Cannabis News and #Stocks on the Move-Episode 638: New #Legalization Following #Midterms
Investor Ideas #Potcasts, #Cannabis News and #Stocks on the Move-Episode 638: New #Legalization Following #Midterms
Delta, Kelowna, BC, November 10, 2022 (Investorideas.com Newswire), investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site release today’s podcast edition of cannabis news and stocks to watch plus insight from thought leaders and experts.
Listen to the podcast:
https://www.investorideas.com/Audio/Podcasts/2022/111022-StocksToWatch.mp3
Read this in full at https://www.investorideas.com/news/2022/cannabis-potcasts/11101New-Legalization-Following-Midterms.asp
Hear Investor ideas cannabis potcast on iTunes
Hear the investor ideas potcast on Spotify
Today’s podcast overview/transcript:
In today’s podcast we look at the recent Midterm results and how this impacted cannabis legalisation and decriminalisation in the U.S.
Maryland and Missouri joined 19 other states and the District of Columbia in legalising recreational cannabis, while legalisation proposals did not pass in Arkansas, North Dakota and South Dakota.
Following the passage of Maryland’s Question 4, adults in the state will be allowed to possess up to 1.5 ounces, or two marijuana plants, beginning July 1, 2023. The amendment also allows for the expungement of records for people arrested for cannabis possession, and for people serving time for simple possession to have their sentences reconsidered. It would also establish a cannabis business assistance fund for small businesses, as well as minority- and women-owned businesses, entering the cannabis industry. Laws surrounding liscensing and taxation still need to be determined.
In Missouri, voters approved the state’s Amendment 3, which removes existing prohibitions on marijuana and allows adults to purchase and possess up to three ounces and grow up to six flowering plants at home. A 6% sales tax will go toward facilitating automatic expungements for certain nonviolent cannabis offences, veterans’ health care, substance misuse treatment and the state’s public defender system. It also adds at least 144 new small business licensees to the existing businesses licensed for medical marijuana, according to Legal Missouri 2022, the advocacy group that sponsored the measure. New licence holders will be selected by lottery.
While these two states moving forward was another great win for cannabis advocacy, are states saw more of the same as voters in Arkansas rejected Issue 4, which would have allowed for the purchase of up to an ounce of marijuana from licensed retailers, and in North Dakota, voters rejected Measure 2, which would have allowed for the possession of up to an ounce of marijuana and finally voters in South Dakota rejected Measure 27, which would have legalised possession of up to one ounce of marijuana.
Moving away from the State level, voters in five Texas cities decided in favour of municipal ballot initiatives eliminating the local enforcement of low-level cannabis offences.
Voters in the cities of Denton, Killeen, San Marcos, Elgin and Harker Heights decided ‘yes’ on the measures. Specifically, the ordinances limit local law enforcement from making arrests or issuing citations for most marijuana-related violations. It also prohibits police in most circumstances from considering the odour of cannabis as probable cause of a crime.
Local activists are anticipated to place ballot questions before voters in additional cities in the coming year.
Meanwhile in Colorado, Proposition 122, Access to Natural Psychedelic Substances, was passed with about 51% of the vote according to the Secretary of State’s Office.
Possession, use, cultivation and sharing of psilocybin, ibogaine, mescaline (not derived from peyote), DMT and psilocyn will be legalised for adults 21 and older, without an explicit possession limit. There will be no recreational sales component.
The Department of Regulatory Agencies will be responsible for developing rules for a therapeutic psychedelics program where adults 21 and older can visit a licensed healing centre to receive treatment under the guidance of a trained facilitator.
There will be a two-tiered regulatory model, where only psilocybin and psilocyn will be permitted for therapeutic use at licensed healing centres until June 2026. After that point, regulators can decide whether to also permit regulated therapeutic use of DMT, ibogaine and mescaline.
This makes Colorado the second state, following Oregan, to legalise psychedelic substances.
With another Midterm election over the US continues its slow march forward with regards to drug reform policy but like most of the world, including Canada, when it comes to dealing with the many who are in prison for cannabis offences, there is still much lacking.
When it comes to Biden's pardons announced Oct. 6, only about 6,500 people convicted of cannabis possession at the federal level were affected. None remain in prison. Without a felony on their record, they won't be tripped up when applying for a job or trying to rent an apartment.
While this is a clear positive, Biden's pardon does not affect some 3,000 people convicted of higher level marijuana crimes who remain in federal prisons, and as many as 30,000 who are still in prison in several states, according to the advocacy group the Last Prisoner Project. Those numbers do not reflect people with convictions for marijuana possession at the state level, although approximately 2 million marijuana convictions have been expunged or pardoned by states where the drug is now legal.
Investor ideas reminds all listeners to read our disclaimers and disclosures on the Investorideas.com website and that this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment.
To hear more Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.
The Investorideas.com podcasts are also available on iTunes ( Apple Podcasts) , Audible , Spotify, Tunein, Stitcher, Spreaker.com, iHeartRadio , Google Podcasts and most audio platforms available.
About Investorideas.com - Big Investing Ideas
We publish breaking stock news, stock research, guest posts and create original top rated investing podcasts, plus sector tag articles featuring up and coming companies and industry leaders. Investor Idea’s original branded content includes the Crypto Corner Podcast , Play by Play Sports Podcast , Cannabis News and Stocks on the Move Podcast , Cleantech and Climate Change Podcast, Exploring Mining Podcast , Betting on Gaming Stocks Podcast and the AI Eye Podcast. We also create free investor stock directories for AI and tech, biotech, cannabis, cleantech, crypto, defense, gaming, health and wellness, mining, oil and gas, sports and water.
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.
Follow us on Twitter https://twitter.com/Investorideas
Follow us on Facebook https://www.facebook.com/Investorideas
Follow us on YouTube https://www.youtube.com/c/Investorideas
Contact Investorideas.com
800 665 0411
Get more Cannabis Stock Investor Ideas – news, articles, podcasts and stock directory
Wednesday 9 November 2022
Subscribe to:
Posts (Atom)
Stocks to Watch Battling the Opioid Epidemic; Stocks Mentioned in this article: Greenlane Holdings, Inc. (NASDAQ: $GNLN), Safe Supply Streaming Co Ltd. (CSE: $SPLY.CN), Nutriband Inc. (NASDAQ: $NTRB), QuidelOrtho Corporation (Nasdaq: $QDEL), Emergent BioSolutions Inc. (NYSE: $EBS)
Stocks to Watch Battling the Opioid Epidemic ; Stocks Mentioned in this article: Greenlane Holdings, Inc. (NASDAQ: $GNLN), Safe Supply St...
-
New #Cannabis Stocks Added to Investor Ideas; (TSX: $FAF.V) (CSE: $STIL.C) (CSE: $ORCD.C) (CSE: $VREO.C) (CSE: $PUMP.C) (OTC: $NUGL) ... -
Investor Ideas #Potcasts #Cannabis News and Stocks on the Move: Dixie Brands (CSE: $DIXI_U.C) (OTC: $DXBRF), Khiron Life Sciences (T... -
Investorideas.com - CBD Stock News: InnoCan Pharma (CSE: INNO) Announces the Successful Completion of an Independent Clinical Study Demonstr...